Ukhyun Jo

1.5k total citations
44 papers, 984 citations indexed

About

Ukhyun Jo is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Ukhyun Jo has authored 44 papers receiving a total of 984 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 27 papers in Oncology and 5 papers in Cell Biology. Recurrent topics in Ukhyun Jo's work include DNA Repair Mechanisms (16 papers), PARP inhibition in cancer therapy (14 papers) and Cancer therapeutics and mechanisms (10 papers). Ukhyun Jo is often cited by papers focused on DNA Repair Mechanisms (16 papers), PARP inhibition in cancer therapy (14 papers) and Cancer therapeutics and mechanisms (10 papers). Ukhyun Jo collaborates with scholars based in United States, South Korea and Japan. Ukhyun Jo's co-authors include Yves Pommier, Yeul Hong Kim, Liton Kumar Saha, Hyungjin Kim, Kyong Hwa Park, Yasuhisa Murai, Sourav Saha, Yilun Sun, Jae Sook Sung and Young Mi Whang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Communications.

In The Last Decade

Ukhyun Jo

40 papers receiving 969 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ukhyun Jo United States 20 782 458 148 115 91 44 984
Liz J. Valente Australia 12 680 0.9× 443 1.0× 180 1.2× 67 0.6× 84 0.9× 13 884
Joshua T. Burgess Australia 14 609 0.8× 455 1.0× 172 1.2× 134 1.2× 53 0.6× 31 933
Sandra Muñoz-Galván Spain 18 661 0.8× 387 0.8× 215 1.5× 103 0.9× 132 1.5× 40 1.0k
Alessandra Bisio Italy 20 633 0.8× 408 0.9× 258 1.7× 100 0.9× 48 0.5× 48 943
Magali Rebucci France 9 509 0.7× 410 0.9× 312 2.1× 125 1.1× 78 0.9× 11 935
Zhibo Yang China 13 487 0.6× 362 0.8× 150 1.0× 70 0.6× 85 0.9× 35 825
Rezina Arju United States 11 617 0.8× 254 0.6× 168 1.1× 92 0.8× 65 0.7× 16 933
Carsten P. Ade Germany 18 708 0.9× 321 0.7× 193 1.3× 104 0.9× 119 1.3× 35 1.0k
Marco Cirò Italy 10 859 1.1× 320 0.7× 225 1.5× 90 0.8× 87 1.0× 11 1.1k
Mazvita Maziveyi United States 7 588 0.8× 261 0.6× 280 1.9× 89 0.8× 90 1.0× 9 858

Countries citing papers authored by Ukhyun Jo

Since Specialization
Citations

This map shows the geographic impact of Ukhyun Jo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ukhyun Jo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ukhyun Jo more than expected).

Fields of papers citing papers by Ukhyun Jo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ukhyun Jo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ukhyun Jo. The network helps show where Ukhyun Jo may publish in the future.

Co-authorship network of co-authors of Ukhyun Jo

This figure shows the co-authorship network connecting the top 25 collaborators of Ukhyun Jo. A scholar is included among the top collaborators of Ukhyun Jo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ukhyun Jo. Ukhyun Jo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jo, Ukhyun, Yasuhiro Arakawa, Astrid Zimmermann, et al.. (2024). The Novel ATR Inhibitor Tuvusertib (M1774) Induces Replication Protein Overexpression and Broad Synergy with DNA-targeted Anticancer Drugs. Molecular Cancer Therapeutics. 23(7). 911–923. 10 indexed citations
2.
Murai, Junko, Michele Ceribelli, Haiqing Fu, et al.. (2023). Schlafen 11 (SLFN11) Kills Cancer Cells Undergoing Unscheduled Re-replication. Molecular Cancer Therapeutics. 22(8). 985–995. 5 indexed citations
3.
Saha, Liton Kumar, Sourav Saha, Xi Yang, et al.. (2023). Replication-associated formation and repair of human topoisomerase IIIα cleavage complexes. Nature Communications. 14(1). 1925–1925. 14 indexed citations
4.
Jo, Ukhyun, Yasuhiro Arakawa, Astrid Zimmermann, et al.. (2023). Abstract LB301: Molecular pharmacology and broad synergy of the novel ATR inhibitor M1774 with DNA damaging anticancer agents. Cancer Research. 83(8_Supplement). LB301–LB301. 1 indexed citations
5.
Jo, Ukhyun, Yasuhisa Murai, Keli Agama, et al.. (2022). TOP1-DNA Trapping by Exatecan and Combination Therapy with ATR Inhibitor. Molecular Cancer Therapeutics. 21(7). 1090–1102. 30 indexed citations
6.
Murai, Yasuhisa, Ukhyun Jo, Yasuhiro Arakawa, Naoko Takebe, & Yves Pommier. (2022). SLFN11’s surveillance role in protein homeostasis. Oncoscience. 9. 35–37.
7.
Murai, Yasuhisa, Ukhyun Jo, Junko Murai, et al.. (2021). SLFN11 Inactivation Induces Proteotoxic Stress and Sensitizes Cancer Cells to Ubiquitin Activating Enzyme Inhibitor TAK-243. Cancer Research. 81(11). 3067–3078. 33 indexed citations
8.
Jo, Ukhyun, Ilya S. Senatorov, Astrid Zimmermann, et al.. (2021). Novel and Highly Potent ATR Inhibitor M4344 Kills Cancer Cells With Replication Stress, and Enhances the Chemotherapeutic Activity of Widely Used DNA Damaging Agents. Molecular Cancer Therapeutics. 20(8). 1431–1441. 75 indexed citations
9.
Saha, Liton Kumar, Yasuhisa Murai, Sourav Saha, et al.. (2021). Replication-dependent cytotoxicity and Spartan-mediated repair of trapped PARP1–DNA complexes. Nucleic Acids Research. 49(18). 10493–10506. 22 indexed citations
10.
Murai, Yasuhisa, Ukhyun Jo, Junko Murai, et al.. (2021). Schlafen 11 expression in human acute leukemia cells with gain-of-function mutations in the interferon-JAK signaling pathway. iScience. 24(10). 103173–103173. 10 indexed citations
11.
Kang, Jin-Ho, Yoon Ji Choi, Ukhyun Jo, et al.. (2019). A Selective FGFR inhibitor AZD4547 suppresses RANKL/M-CSF/OPG-dependent ostoclastogenesis and breast cancer growth in the metastatic bone microenvironment. Scientific Reports. 9(1). 8726–8726. 19 indexed citations
12.
Wang, Jingming, Bryan Chan, Michael Tong, et al.. (2019). Prolyl isomerization of FAAP20 catalyzed by PIN1 regulates the Fanconi anemia pathway. PLoS Genetics. 15(2). e1007983–e1007983. 10 indexed citations
13.
Li, Heng, Kah Suan Lim, Hyungjin Kim, et al.. (2016). Allosteric Activation of Ubiquitin-Specific Proteases by β-Propeller Proteins UAF1 and WDR20. Molecular Cell. 63(2). 249–260. 55 indexed citations
14.
Jo, Ukhyun, et al.. (2016). PCNA-Dependent Cleavage and Degradation of SDE2 Regulates Response to Replication Stress. PLoS Genetics. 12(12). e1006465–e1006465. 30 indexed citations
15.
Jo, Ukhyun, Hye Jin Lee, Jin-Ho Kang, et al.. (2014). Vaccination with ErbB-2 peptides prevents cancer stem cell expansion and suppresses the development of spontaneous tumors in MMTV-PyMT transgenic mice. Breast Cancer Research and Treatment. 147(1). 69–80. 13 indexed citations
16.
Chan, Chia‐Hsin, Ukhyun Jo, Abraham Q. Kohrman, et al.. (2014). Posttranslational regulation of Akt in human cancer. Cell & Bioscience. 4(1). 59–59. 109 indexed citations
17.
Kim, Seung Tae, Hae‐Yun Jung, Jae Sook Sung, et al.. (2012). Can Serum be Used for Analyzing the EGFR Mutation Status in Patients with Advanced Non-small Cell Lung Cancer?. American Journal of Clinical Oncology. 36(1). 57–63. 24 indexed citations
18.
Kim, Sunyong, et al.. (2011). A Case of Chronic Neuropathic Pseudo-obstruction of the Colon. Clinical Endoscopy. 42(3). 179–184. 1 indexed citations
19.
Whang, Young Mi, Kyong Hwa Park, Hae‐Yun Jung, Ukhyun Jo, & Yeul Hong Kim. (2009). Microtubule‐damaging agents enhance RASSF1A‐induced cell death in lung cancer cell lines. Cancer. 115(6). 1253–1266. 7 indexed citations
20.
Yoo, Wonbeak, et al.. (2007). P2-033: Polymorphisms of Jak3 contribute to diminished promoter activity and increased risk of lung cancer in Korea populations. Journal of Thoracic Oncology. 2(8). S495–S495. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Liz J. Valente Breakdown of academic impact, for papers by Joshua T. Burgess Breakdown of academic impact, for papers by Sandra Muñoz-Galván Breakdown of academic impact, for papers by Alessandra Bisio Breakdown of academic impact, for papers by Magali Rebucci Breakdown of academic impact, for papers by Zhibo Yang Breakdown of academic impact, for papers by Rezina Arju Breakdown of academic impact, for papers by Carsten P. Ade Breakdown of academic impact, for papers by Marco Cirò Breakdown of academic impact, for papers by Mazvita Maziveyi
Rankless by CCL
2026